Jan 27, 2017 at 14:58 | Source: PTI
The company had posted a net loss of Rs 41.02 crore for the same period of previous fiscal, SPARC said in a regulatory filing.
Dec 22, 2016 at 22:08 | Source:
SP Tulsian of, talks about why he is bullish on Hindustan Zinc and other non-ferrous metal stocks. He also gives his views on the non-banking financial companies (NBFC).
Dec 22, 2016 at 13:25 | Source:
Shares of Sun Pharma Advanced Research Company, the subsidiary of healthcare major Sun Pharmaceutical, surged nearly 7 percent intraday Thursday after receiving complete response letter from the US health regulator for preservative-free eye drop.
Dec 22, 2016 at 11:00 | Source:
The selling pressure continued for the seventh consecutive session today due to lack of positive triggers. The market may be factoring in the impact of demonetisation on December quarter earnings, December sales data and economic data that will be announced next month.
Dec 22, 2016 at 10:33 | Source: CNBC-TV18
SPARC has received a complete response letter (CRL) from USFDA for their new drug application (NDA) on Xelpros, which is an eye drop studied by SPARC, reports CNBC-TV18.
Nov 01, 2016 at 07:52 | Source:
Gaurav Ratnaparkhi of Sharekhan advises buying CESC with a target of Rs 655.
Oct 28, 2016 at 15:14 | Source: PTI
The company had posted a net loss of Rs 17.74 crore in the corresponding period of the previous fiscal, Sun Pharma Advanced Research Company (SPARC) said in a filing to BSE.
Aug 05, 2016 at 11:13 | Source: CNBC-TV18
Mitesh Thacker of is of the view that one may buy Tata Steel and advises selling Infosys.
Aug 05, 2016 at 09:27 | Source: CNBC-TV18
Rajat Bose of feels that Cadila Healthcare may test Rs 393.
Aug 04, 2016 at 16:40 | Source: CNBC-TV18
Mitesh Thacker of advises buying Sun Pharma Advanced Research Company.
Messages on Sparc »


Platinum Member


Sun Pharma Adv  

Sun Pharma research arm SPARC gets income tax demand notice for Rs32.87 crore

8.52 PM Feb 24th


New Member


Sun Pharma Adv  

I think SPARC will go up today, Target for 326-329.2

1.10 PM Feb 21st

BSE/NSE Announcer

Platinum Member


Sparc Systems  

Sparc Systems Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016

6.08 PM Feb 14th


Platinum Member


Aurobindo Pharm  

a range of integrated end-to-end discovery and development services for novel molecular entities with the help of over 2,500 research scientists. The R&D expenditure as percentage of net sales of Sun Pharma Advance Research Company (SPARC) worked out to over 146 per cent during 2015-16 as compared

4.44 PM Feb 8th

Sun Pharma Adv  

sell sparc tgt 240 and sl of 330

10.42 AM Feb 8th

Sun Pharma Adv  

Dishman and sparc to join hands to mkt products dishman tgt 290 and sparc 400 huge news mergeing of products

10.31 AM Feb 8th

Dishman Pharma  

Dishman pharma and sparc merger huge huge dishman to benefit

10.28 AM Feb 8th

Dishman Pharma  

Dishman pharma and sparc to join hands huge huge news for dishman

10.22 AM Feb 8th


New Member

0 Follower

Sun Pharma Adv  

this is the forum for sparc.. plz dont put unnecessary comments of coffee enterprise here

2.27 PM Feb 7th

Wire News

Platinum Member


News Now  

Sun Pharma Advanced Research Company (SPARC) today reported a net loss of Rs 66.33 crore for the third quarter ended December 31, 2016.

2.58 PM Jan 27th

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.